Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$1.05B |
| 2 |
Peloton Interactive
PTON
|
$691M |
| 3 |
DoorDash
DASH
|
$456M |
| 4 |
Certara
CERT
|
$393M |
| 5 |
Service Corp International
SCI
|
$374M |
Top Sells
| 1 |
Alibaba
BABA
|
$2.33B |
| 2 |
Tesla
TSLA
|
$1.55B |
| 3 |
Moderna
MRNA
|
$1.41B |
| 4 |
Amazon
AMZN
|
$884M |
| 5 |
NetEase
NTES
|
$692M |
Sector Composition
| 1 | Consumer Discretionary | 27.71% |
| 2 | Healthcare | 26.02% |
| 3 | Technology | 19.32% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Clover Health Investments
CLOV
$1.38B
| $38M | 0.02% |
5,142,177
| – | – |
|
202
Cisco
CSCO
$269B
| $37.4M | 0.02% |
687,555
+3,186
| +0.5% | +$173K |
|
|
ZY
203
DELISTED
Zymergen Inc. Common Stock
ZY
| $37.2M | 0.02% |
2,821,956
| – | – |
|
204
Sutro Biopharma
STRO
$86.5M
| $33.9M | 0.02% |
1,794,940
+767
| +0% | +$14.5K |
|
205
Starbucks
SBUX
$98.9B
| $32.9M | 0.02% |
+298,468
| New | +$32.9M |
|
206
Quanterix
QTRX
$201M
| $30M | 0.02% |
601,558
+387
| +0.1% | +$19.3K |
|
|
AMBR
207
Amber International Holding Limited American Depositary Shares
AMBR
$354M
| $29.5M | 0.02% |
532,689
+48,129
| +10% | +$2.66M |
|
208
Veeco
VECO
$1.44B
| $29.2M | 0.02% |
1,314,844
-14,485
| -1% | -$322K |
|
209
Cullen/Frost Bankers
CFR
$8.38B
| $29.1M | 0.02% |
245,722
+1,549
| +0.6% | +$184K |
|
210
Digimarc
DMRC
$175M
| $28.5M | 0.01% |
826,584
-9,861
| -1% | -$340K |
|
|
TRHC
211
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $27.5M | 0.01% |
1,049,499
-7,218
| -0.7% | -$189K |
|
212
Dolby
DLB
$6.98B
| $27.5M | 0.01% |
312,104
+5,152
| +2% | +$453K |
|
|
BZUN
213
Baozun
BZUN
$223M
| $26.3M | 0.01% |
1,501,340
-12,408
| -0.8% | -$218K |
|
214
Waters Corp
WAT
$17.8B
| $25.1M | 0.01% |
70,133
+998
| +1% | +$357K |
|
215
EverQuote
EVER
$869M
| $25M | 0.01% |
1,339,621
-9,962
| -0.7% | -$186K |
|
216
Masimo
MASI
$7.77B
| $23.4M | 0.01% |
86,368
+9,040
| +12% | +$2.45M |
|
217
QuantumScape
QS
$4.33B
| $22.5M | 0.01% |
916,109
+2,830
| +0.3% | +$69.4K |
|
218
Golub Capital BDC
GBDC
$3.94B
| $22.3M | 0.01% |
+1,412,330
| New | +$22.3M |
|
|
MEKA
219
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $22.1M | 0.01% |
+2,000,000
| New | +$22.1M |
|
220
BridgeBio Pharma
BBIO
$9.91B
| $21.8M | 0.01% |
465,876
+45,984
| +11% | +$2.16M |
|
221
American Superconductor
AMSC
$2.19B
| $21.7M | 0.01% |
1,491,370
+211,970
| +17% | +$3.09M |
|
|
API
222
Agora
API
$299M
| $21.6M | 0.01% |
744,300
| – | – |
|
|
223
NetEase
NTES
$84.3B
| $21.5M | 0.01% |
252,028
-8,105,507
| -97% | -$692M |
|
224
Butterfly Network
BFLY
$385M
| $21M | 0.01% |
2,015,008
+72,272
| +4% | +$754K |
|
225
CEVA Inc
CEVA
$534M
| $20.5M | 0.01% |
479,464
-1,668
| -0.3% | -$71.2K |
|